Eldon C. Mayer, III
2018
In 2018, Eldon C. Mayer, III earned a total compensation of $1.6M as Executive Vice President, Chief Commercial Officer at Rigel Pharmaceuticals, a 122% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $317,760 |
|---|---|
| Option Awards | $863,124 |
| Salary | $400,015 |
| Other | $3,354 |
| Total | $1,584,252 |
Mayer received $863.1K in option awards, accounting for 54% of the total pay in 2018.
Mayer also received $317.8K in non-equity incentive plan, $400K in salary and $3.4K in other compensation.
Rankings
In 2018, Eldon C. Mayer, III's compensation ranked 6,899th out of 14,244 executives tracked by ExecPay. In other words, Mayer earned more than 51.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,899 out of 14,244 | 52nd |
Division Manufacturing | 2,646 out of 5,765 | 54th |
Major group Chemicals And Allied Products | 1,000 out of 2,128 | 53rd |
Industry group Drugs | 841 out of 1,817 | 54th |
Industry Pharmaceutical Preparations | 656 out of 1,391 | 53rd |
Source: SEC filing on April 9, 2019.
Mayer's colleagues
We found five more compensation records of executives who worked with Eldon C. Mayer, III at Rigel Pharmaceuticals in 2018.
2018
Raul Rodriguez
Rigel Pharmaceuticals
Chief Executive Officer
2018
Dolly Vance
Rigel Pharmaceuticals
General Counsel
2018
Anne-Marie Duliege
Rigel Pharmaceuticals
Chief Medical Officer
2018
Esteban Masuda
Rigel Pharmaceuticals
Executive Vice President, Research
2018
Dean Schorno
Rigel Pharmaceuticals